Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world tildrakizumab in psoriasis vulgaris (Japan)
jRCTs031250212Active, not recruiting
- Sponsor
- Sun Pharma
- Start
- Jul 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of tildrakizumab in plaque psoriasis, sponsored by Sun Pharma. Primary endpoint: sPGA (0/1) achievement rate at week 28. Started Jul 2025; status: active, not recruiting.
02
Drugs
tildrakizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on jRCTs031250212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250212.